No Data
No Data
Recursion Pharmaceuticals(RXRX.US) Officer Sells US$26,325 in Common Stock
$Recursion Pharmaceuticals(RXRX.US)$ Officer Marriott Tina sold 3,000 shares of common stock on May 30, 2024 at an average price of $8.775 for a total value of $26,325.Source: Announcement What is sta
Recursion to Participate in Upcoming Investor Conferences
SALT LAKE CITY, June 03, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ:RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its participation in the following
Is Recursion Pharmaceuticals Stock a Millionaire-Maker?
Insider Sale: Director Blake Borgeson Sells Shares of Recursion Pharmaceuticals Inc (RXRX)
Recursion Pharmaceuticals(RXRX.US) Director Sells US$104.94K in Common Stock
$Recursion Pharmaceuticals(RXRX.US)$ Director Borgeson Blake sold 11,447 shares of common stock on May 28, 2024 at an average price of $9.1677 for a total value of $104.94K.Source: Announcement What i
How Is The Market Feeling About Recursion Pharmaceuticals?
Recursion Pharmaceuticals's (NYSE:RXRX) short percent of float has risen 4.63% since its last report. The company recently reported that it has 42.37 million shares sold short, which is 26.88% of all
No Data